Surgalign Inc. (SRGA)
Surgalign Statistics
Share Statistics
Surgalign has 0 shares outstanding. The number of shares has increased by -28.01% in one year.
| Shares Outstanding | 0 |
| Shares Change (YoY) | -28.01% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 6.65M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.24 and the forward PE ratio is null. Surgalign's PEG ratio is 0.
| PE Ratio | -0.24 |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | null |
| PB Ratio | -0.51 |
| P/FCF Ratio | -0.22 |
| PEG Ratio | 0 |
Enterprise Valuation
Surgalign has an Enterprise Value (EV) of 6.94M.
| EV / Sales | 0.08 |
| EV / EBITDA | -0.1 |
| EV / EBIT | -0.13 |
| EV / FCF | -0.12 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of -0.4.
| Current Ratio | 2.68 |
| Quick Ratio | 1.84 |
| Debt / Equity | -0.4 |
| Debt / EBITDA | -0.15 |
| Debt / FCF | -0.17 |
| Interest Coverage | -69.81 |
Financial Efficiency
Return on Equity is 212.23% and Return on Invested Capital is 444.86%.
| Return on Equity | 212.23% |
| Return on Assets | -77.74% |
| Return on Invested Capital | 444.86% |
| Revenue Per Employee | $377.78K |
| Profits Per Employee | $-251.64K |
| Employee Count | 217 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 2.35 |
Taxes
| Income Tax | -1.04M |
| Effective Tax Rate | 1.87% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.8, so Surgalign's price volatility has been higher than the market average.
| Beta | 1.8 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 29.97 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Surgalign had revenue of 81.98M and earned -54.6M in profits. Earnings per share was -8.33.
| Revenue | 81.98M |
| Gross Profit | 40.29M |
| Operating Income | -70.44M |
| Net Income | -54.6M |
| EBITDA | -68.28M |
| EBIT | -54.64M |
| Earnings Per Share (EPS) | -8.33 |
Balance Sheet
The company has 16.3M in cash and 10.19M in debt, giving a net cash position of 6.1M.
| Cash & Cash Equivalents | 16.3M |
| Total Debt | 10.19M |
| Net Cash | 6.1M |
| Retained Earnings | -624.22M |
| Total Assets | 67.71M |
| Working Capital | 33.45M |
Cash Flow
In the last 12 months, operating cash flow was -52.11M and capital expenditures -7.26M, giving a free cash flow of -59.37M.
| Operating Cash Flow | -52.11M |
| Capital Expenditures | -7.26M |
| Free Cash Flow | -59.37M |
| FCF Per Share | -9.06 |
Margins
Gross margin is 49.14%, with operating and profit margins of -85.92% and -66.61%.
| Gross Margin | 49.14% |
| Operating Margin | -85.92% |
| Pretax Margin | -67.88% |
| Profit Margin | -66.61% |
| EBITDA Margin | -83.29% |
| EBIT Margin | -85.92% |
| FCF Margin | -72.41% |
Dividends & Yields
SRGA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -418.59% |
| FCF Yield | -455.08% |
Analyst Forecast
Currently there are no analyst rating for SRGA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 17, 2022. It was a backward split with a ratio of 1:30.
| Last Split Date | May 17, 2022 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -14.13 |
| Piotroski F-Score | 2 |